The t(5;12) (q31-35;p12-13) translocation is rare among cytogenetically categorized myeloid diseases. Here we describe a case of MDS with basophilia followed by leukocytosis, basophilia and eosinophilia with t(5;12)(q31;p13).
WBC count temporarily increased to maximum of 87.3 × 10 9 l -1 , and then gradually decreased. Three months later, he received unrelated allogenic bone marrow transplantation following a myeloablative preparation regimen of cyclophosphamide (120mg/kg) and total body irradiation (12Gy) in March 2006. Currently, he is healthy with negative test for t(5;12)(q31;p13).
Recently, human long fatty a cyl C oA s ynthetase gene, ACS2, on 5q31 was identified as a fusion partner of ETV6 in acute myeloid leukemia (AML) and MDS cases with t(5;12)(q31;p13) [1] . We also performed RT-PCR for ETV6-ACS2 from the bone marrow cells following the published method [1] and an amplified DNA fragment was detected ( fig.1A ). DNA sequencing of the DNA fragment revealed an out-frame fusion of exon 1 of ETV6 gene to exon 1 of ACS2 gene ( fig.1B) .
Expressions of interleukin-3 (IL-3) or nterleukin-5 (IL-5) were detected in the bone marrow cells of our case while no expression was seen in controls ( fig.1C,D) , which may be related to the cause of eosinophilia or basophilia as previously suggested [2, 3] .
We have summarized the published reports of hematological disorders accompanied by t(5;12)(q31;p12-13) ( [14] . The translocation juxtaposes the ETV6 gene with the platelet-derived growth factor receptor β (PDGFRβ) gene. It is of clinical importance that imanitib mesylate is effective for patients with rearrangement of the PDGFRβ gene [15] . Our patient received a course of imatinib without response.
It is important to determine the precise breakpoint or identify the fusion gene in hematological malignancy with t(5;12) to ensure an appropriate choice of therapy.
We experienced a rare case of MDS with t(5;12)(q31;p13) with basophilia and eosinophilia. Further studies are needed to understand the precise mechanism of disease by the translocation or the resultant fusion gene.
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